%0 Journal Article
%U http://www.molvis.org/molvis/v19/894
%> mv-v19-894.pdf
%A  Fernandez-Bueno,  I.
%A  Garcia-Gutierrez,  M.T.
%A  Srivastava,  G.K.
%A  Gayoso,  M.J.
%A  Gonzalo-Orden,  J.M.
%A  Pastor,  J.C.
%T Adalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina
%D 2013
%V 19
%P 894-903
%J Molecular Vision